HERDOO2 Rule for Discontinuing Anticoagulation in Unprovoked VTE
HERDOO2 identifies women with unprovoked VTE who have 0–1 risk factors as low risk and safe to stop anticoagulation after initial therapy.
Indikationen
Stop anticoagulation only in women with a first unprovoked VTE who, after 5–12 months of treatment, have 0–1 HERDOO2 criteria, identifying a low‑risk group (~3%/year recurrence) validated in a multinational cohort 1 [Level I evidence]. Positive criteria (leg hyperpigmentation/edema/redness, D‑dimer ≥250 µg/L, BMI ≥30, age ≥65) or any man indicate higher recurrence risk and favor continued therapy 2 [Level II evidence].
Hinweise & Vorsichtsmaßnahmen
Low‑risk women (0–1 criteria) can stop anticoagulation after 5–12 months with an annual recurrence of about 3% 1 [Level I evidence].
Cautions: applies only to women with first unprovoked VTE; men and women with ≥2 criteria have far higher recurrence (~8%/yr) and should continue therapy. ACC guidance notes it is a validated tool but limited to identifying low‑risk women only 2 [Level I evidence].